Inogen Price to Book Ratio 2012-2023 | INGN
Historical price to book ratio values for Inogen (INGN) over the last 10 years. The current price to book ratio for Inogen as of April 17, 2024 is 0.79.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Inogen Price/Book Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | Book Value per Share | Price to Book Ratio |
2024-04-17 | 6.95 | 0.79 | |
2023-12-31 | 5.49 | $8.78 | 0.63 |
2023-09-30 | 5.22 | $9.90 | 0.53 |
2023-06-30 | 11.55 | $11.85 | 0.97 |
2023-03-31 | 12.48 | $12.17 | 1.03 |
2022-12-31 | 19.71 | $12.96 | 1.52 |
2022-09-30 | 24.28 | $15.31 | 1.59 |
2022-06-30 | 24.18 | $15.59 | 1.55 |
2022-03-31 | 32.42 | $15.69 | 2.07 |
2021-12-31 | 34.00 | $16.29 | 2.09 |
2021-09-30 | 43.09 | $17.20 | 2.50 |
2021-06-30 | 65.17 | $16.43 | 3.97 |
2021-03-31 | 52.52 | $15.92 | 3.30 |
2020-12-31 | 44.68 | $15.80 | 2.83 |
2020-09-30 | 29.00 | $15.94 | 1.82 |
2020-06-30 | 35.52 | $15.91 | 2.23 |
2020-03-31 | 51.66 | $15.75 | 3.28 |
2019-12-31 | 68.33 | $15.64 | 4.37 |
2019-09-30 | 47.91 | $15.60 | 3.07 |
2019-06-30 | 66.76 | $15.22 | 4.39 |
2019-03-31 | 95.37 | $14.68 | 6.50 |
2018-12-31 | 124.17 | $14.25 | 8.71 |
2018-09-30 | 244.12 | $13.55 | 18.02 |
2018-06-30 | 186.33 | $12.52 | 14.89 |
2018-03-31 | 122.84 | $11.61 | 10.58 |
2017-12-31 | 119.08 | $10.82 | 11.00 |
2017-09-30 | 95.10 | $10.61 | 8.96 |
2017-06-30 | 95.42 | $10.03 | 9.51 |
2017-03-31 | 77.56 | $9.38 | 8.27 |
2016-12-31 | 67.17 | $8.93 | 7.52 |
2016-09-30 | 59.90 | $7.71 | 7.77 |
2016-06-30 | 50.11 | $7.35 | 6.82 |
2016-03-31 | 44.98 | $6.95 | 6.47 |
2015-12-31 | 40.09 | $6.77 | 5.92 |
2015-09-30 | 48.55 | $6.63 | 7.32 |
2015-06-30 | 44.60 | $6.61 | 6.75 |
2015-03-31 | 31.99 | $6.36 | 5.03 |
2014-12-31 | 31.37 | $6.20 | 5.06 |
2014-09-30 | 20.61 | $6.18 | 3.34 |
2014-06-30 | 22.56 | $6.08 | 3.71 |
2014-03-31 | 16.51 | $5.94 | 2.78 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $0.162B | $0.316B |
Inogen Inc. develops, manufactures and markets POC. POCs are used by patients who suffer from chronic respiratory conditions and need long-term oxygen therapy. POCs concentrate the air around the patient, filter out the nitrogen and other unwanted substances and deliver oxygen. The company provides oxygen concentrator solutions for portable and stationary use. Inogen's flagship product, One G4 is a single-solution POC. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $211.679B | 25.75 |
Intuitive Surgical (ISRG) | United States | $134.177B | 83.75 |
Edwards Lifesciences (EW) | United States | $54.204B | 35.88 |
DexCom (DXCM) | United States | $52.631B | 90.41 |
IQVIA Holdings (IQV) | United States | $41.589B | 24.67 |
IDEXX Laboratories (IDXX) | United States | $40.661B | 48.62 |
Alcon (ALC) | Switzerland | $39.256B | 28.95 |
STERIS (STE) | Ireland | $19.665B | 23.28 |
Waters (WAT) | United States | $18.607B | 26.70 |
Hologic (HOLX) | United States | $17.631B | 19.46 |
SONOVA HOLDING (SONVY) | Switzerland | $16.535B | 0.00 |
ShockWave Medical (SWAV) | United States | $12.247B | 84.62 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $10.915B | 13.48 |
Sysmex ADR (SSMXY) | Japan | $9.988B | 31.32 |
Teleflex (TFX) | United States | $9.896B | 15.54 |
Penumbra (PEN) | United States | $8.130B | 100.50 |
Masimo (MASI) | United States | $7.312B | 41.00 |
Globus Medical (GMED) | United States | $7.011B | 22.23 |
Glaukos (GKOS) | United States | $4.796B | 0.00 |
Integer Holdings (ITGR) | United States | $3.997B | 25.55 |
TransMedics (TMDX) | United States | $3.052B | 0.00 |
LivaNova (LIVN) | United Kingdom | $2.869B | 18.92 |
Elekta AB (EKTAY) | Sweden | $2.673B | 18.34 |
PROCEPT BioRobotics (PRCT) | United States | $2.650B | 0.00 |
Integra LifeSciences Holdings (IART) | United States | $2.501B | 10.27 |
Nihon Kohden (NHNKY) | Japan | $2.368B | 20.03 |
Inari Medical (NARI) | United States | $2.266B | 391.00 |
Tandem Diabetes Care (TNDM) | United States | $2.128B | 0.00 |
RxSight (RXST) | United States | $2.009B | 0.00 |
Alphatec Holdings (ATEC) | United States | $1.820B | 0.00 |
Veracyte (VCYT) | United States | $1.420B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.862B | 15.94 |
OPKO Health (OPK) | United States | $0.843B | 0.00 |
Artivion (AORT) | United States | $0.837B | 96.71 |
Paragon 28 (FNA) | United States | $0.799B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.718B | 0.00 |
Treace Medical Concepts (TMCI) | United States | $0.712B | 0.00 |
Silk Road Medical (SILK) | United States | $0.694B | 0.00 |
SiBone (SIBN) | United States | $0.630B | 0.00 |
Mesa Laboratories (MLAB) | United States | $0.553B | 18.77 |
IRadimed (IRMD) | United States | $0.520B | 30.17 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.493B | 0.00 |
Nevro (NVRO) | United States | $0.466B | 0.00 |
Pulse Biosciences (PLSE) | United States | $0.430B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.375B | 0.00 |
NeuroPace (NPCE) | United States | $0.369B | 0.00 |
CVRx (CVRX) | United States | $0.354B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.342B | 11.50 |
AxoGen (AXGN) | United States | $0.306B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.271B | 0.00 |
AngioDynamics (ANGO) | United States | $0.261B | 0.00 |
Sight Sciences (SGHT) | United States | $0.259B | 0.00 |
Accuray (ARAY) | United States | $0.221B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.193B | 0.00 |
908 Devices (MASS) | United States | $0.191B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.190B | 0.00 |
Semler Scientific (SMLR) | United States | $0.183B | 9.84 |
ClearPoint Neuro (CLPT) | United States | $0.151B | 0.00 |
Neuronetics (STIM) | United States | $0.121B | 0.00 |
Delcath Systems (DCTH) | United States | $0.120B | 0.00 |
Envoy Medical (COCH) | United States | $0.117B | 0.00 |
Yubo Biotech (YBGJ) | China | $0.112B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.098B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.090B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.083B | 0.00 |
Hyperfine (HYPR) | United States | $0.071B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.063B | 0.00 |
SEP Acquisition (SEPA) | United States | $0.058B | 0.00 |
Vasomedical (VASO) | United States | $0.057B | 10.32 |
InspireMD (NSPR) | Israel | $0.053B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.052B | 106.67 |
Autonomix Medical (AMIX) | United States | $0.052B | 0.00 |
Vicarious Surgical (RBOT) | United States | $0.052B | 0.00 |
Aspira Women's Health (AWH) | United States | $0.043B | 0.00 |
ReWalk Robotics (LFWD) | Israel | $0.042B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.040B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.039B | 0.00 |
Pixie Dust Technologies (PXDT) | Japan | $0.038B | 0.00 |
Spectral AI (MDAI) | United States | $0.035B | 0.00 |
DarioHealth (DRIO) | United States | $0.034B | 0.00 |
LENSAR (LNSR) | United States | $0.034B | 0.00 |
Precision Optics (POCI) | United States | $0.033B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.024B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.024B | 0.00 |
QT Imaging Holdings (QTI) | United States | $0.018B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.018B | 0.00 |
PAVmed (PAVM) | United States | $0.017B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.017B | 0.00 |
Microbot Medical (MBOT) | United States | $0.014B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.014B | 0.00 |
NexGel (NXGL) | United States | $0.013B | 0.00 |
Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
Avinger (AVGR) | United States | $0.006B | 0.00 |
Venus Concept (VERO) | Canada | $0.005B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.005B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
Tenon Medical (TNON) | United States | $0.003B | 0.00 |
Dynatronics (DYNT) | United States | $0.003B | 0.00 |
Nuwellis (NUWE) | United States | $0.002B | 0.00 |
Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |